![](https://news.europawire.eu/wp-content/uploads/2016/06/medtronic-logo-144x144.jpg)
Launch of 34 mm Self-Expanding Evolut R Device Expands TAVR Treatment to Patients Who Could Not be Treated Previously DUBLIN, 27-Oct-2016 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of … Read the full press release